series-b
Stage
2
Investors
About
NeoTract develops and manufactures minimally invasive medical devices for urologists, primarily focused on treating benign prostatic hyperplasia with products such as the UroLift system.
Explore NEOTRACT's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.